---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018762"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:28:22.101701+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Olema Pharmaceuticals amends bylaws to update stockholder nomination procedures

## Summary
- Board approved amended and restated bylaws effective December 15, 2022.
- Revisions address Rule 14a-19 universal proxy rules and update director nomination information requirements.
- Updated provisions on conduct of stockholder meetings and setting date, time, place.

## SEC filing metadata
- accession: 0001558370-22-018762
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000155837022018762/0001558370-22-018762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000155837022018762/olma-20221215x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018762
- JSON: https://secwatch.observer/filing/0001558370-22-018762.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018762.txt

## Key facts
- Governance Changes
  Olema Pharmaceuticals, Inc.: Amended and restated bylaws to update procedures for stockholder nominations regarding Rule 14a-19, update information requirements for director nominations and other business proposals, and update provisions for stockholder meetings (effective 2022-12-15).
  - Change: bylaw amendment
  - Effective: 2022-12-15
  source text: On December 15, 2022, the Board of Directors (the “ Board ”) of Olema Pharmaceuticals, Inc. (the “ Company ”) approved the amendment and restatement of the Bylaws of the Company (the “ Amended and Restated Bylaws ”). The Amended and Restated Bylaws are effective as of December 15, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000155837022018762/0001558370-22-018762-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.